Author Information

Camile S. Farah is Professor of Oral Oncology, Dean and Head of the UWA Dental School, and Director of the Oral Health Centre of WA, at the University of Western Australia, Perth Australia. He is a registered specialist in both Oral Medicine and Oral Pathology with sub-specialty training in Oral Oncology. He is a Consultant in Oral Medicine at the Oral Health Centre of WA, and maintains a part-time private practice in Oral Medicine at Perth Oral Medicine & Dental Sleep Centre focused on oral mucosal diseases, salivary gland pathology, bone pathology and orofacial pain. He is convenor of the postgraduate training program in Oral Medicine at the UWA Dental School, a member of the Head & Neck Cancer Multidisciplinary Team at Sir Charles Gairdner Hospital, Director of the Australian Centre for Oral Oncology Research & Education, and Consultant at Qscan Radiology Clinics. Camile is a Fellow of the Oral Medicine Academy of Australasia, the International Academy of Oral Oncology, the Royal Australasian College of Dental Surgeons (Oral Medicine), the International College of Dentists, and the Pierre Fauchard Academy. He is the Inaugural and Past President of the Oral Medicine Academy of Australasia, Past President of the Australian & New Zealand Division of the International Association for Dental Research, Chairman-elect of the Australian Dental Research Foundation and past Chairman of its Research Advisory Committee. Camile has authored more than 150 peer reviewed publications including 18 book chapters. He has personally attracted $7.5 million in competitive research funding, been involved in other successful collaborative grants totalling nearly $10 million, and has mentored over 50 postgraduate students and postdoctoral staff. Camile is clinician-scientist with expertise in oral oncological translational research. His clinical and laboratory research focuses on optical imaging modalities, molecular genomics, clinical trials in early detection and oncological surgery, and personalized patient care particularly related to oral cancer and potentially malignant disorders. His laboratory has explored diagnostic biomarker signatures for oral premalignant lesions, predictive biomarker profiles for oral cancer progression, and a multigene discriminatory biomarker panel for oral squamous cell carcinoma and epithelial dysplasia. He is a supporter of patient and clinician education and professional development, and overall advocacy for patients with oral cancer.

Ramesh Balasubramaniam graduated with a BDSc from the University of Western Australia in 2000 and subsequently practiced general dentistry. In 2006, he completed a certificate and Master of Science degree in Orofacial Pain at the University of Kentucky. While at the University of Kentucky, Ramesh also underwent training in the field of Dental Sleep Medicine. He is a Diplomate of the American Board of Orofacial Pain. In addition, Ramesh completed specialist training in Oral Medicine as well as a Fellowship in Interdisciplinary Geriatrics at the University of Pennsylvania in 2008. Ramesh has numerous peer reviewed publications, has contributed to several chapters in various texts and co-edited the May 2008 Oral and Maxillofacial Surgery Clinics of North America on Orofacial Pain and Dysfunction. In addition, he serves as a reviewer for a number of peer-reviewed journals. Ramesh has an appointment as a Clinical Associate Professor at the UWA Dental School, University of Western Australia and is actively involved in teaching and research. He also holds public appointments at the Oral Health Centre of Western Australia and the Perth Children’s Hospital. He is President-elect of the Oral Medicine Academy of Australasia having served as its Secretary. His Oral Medicine Specialist practice focuses on Orofacial Pain, Oral Diseases and Disorders, and Dental Sleep Medicine.

Michael J. McCullough is Professor of Oral Medicine at the Melbourne Dental School, The University of Melbourne. He is the convener of both the post-graduate and graduate courses in Oral Medicine, has published 128 articles in peer reviewed scientific journals, and was on the Expert Panel for both editions of the Therapeutic Guidelines book titled Oral and Dental. Michael is an Oral Medicine Clinical Consultant to the Royal Dental Hospital of Melbourne, the Royal Melbourne Hospital and the University of Melbourne's Dental Clinic. Michael gained a Bachelor Degree in Dental Science in 1982, a Master Degree in Oral Medicine and Oral Pathology and a PhD in 1995, all from Melbourne University. He spent several years as a Post-doctoral Research Fellow at Stanford University in California during 1996 and 1997; followed by 3 years as a Lecturer in Oral Medicine at the Eastman Dental Institute, University College London. Michael has 27 years’ experience in clinical and academic Oral Medicine, was an inaugural Fellow of the Royal Australasian College of Dental Surgeons in Oral Medicine (2005) by examination, and is a Fellow of the International College of Dentists (2012), the Pierre Fauchard Academy (2013), and the Oral Medicine Academy of Australasia (2012). Michael has supervised to completion 18 research higher degree students, and currently he is principal supervisor to 4 PhD students, and co-supervisor to 3 PhD and 6 MPhil students. Michael has published 128 clinical and scientific articles including 3 book chapters. His work is mostly published in ERA A*/A ranked journals in the highest-ranking journals in his specialty.

Michael is the current President of the Oral Medicine Academy of Australasia and the Inaugural Chair of the Australian and New Zealand Council of Dental Specialists. He was the Chairperson of the Dental Therapeutics Committee of the Australian Dental Association from 2006 to 2012 and an active member until 2016. He was on the Expert panel of the Therapeutic Guidelines book, Oral and Dental whose first edition was in 2007, and the revised 2nd edition being published in 2012. Michael has been a member of the Australian Dental Research Foundation's Research Advisory Committee since 2013, and in 2016 became the Chair of this Committee.